Korea Investment Corp’s Ionis Pharmaceuticals IONS Stock Holding History

Korea Investment Corp’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29,900	Closed	-$1.34M	–	749
2021 Q1	$1.34M	Sell	29,900 -9,000	-23%	-$502K	﹤0.01%	677
2020 Q4	$2.2M	Buy	38,900 +4,500	+13%	+$224K	0.01%	649
2020 Q3	$1.63M	Sell	34,400 -1,000	-3%	-$55.5K	0.01%	623
2020 Q2	$2.09M	Buy	35,400 +2,200	+7%	+$122K	0.01%	592
2020 Q1	$1.57M	Buy	+33,200	New	+$1.85M	0.01%	605
2016 Q1	–	Sell	-6,200	Closed	-$383K	–	589
2015 Q4	$383K	Sell	6,200 -18,900	-75%	-$1.02M	﹤0.01%	621
2015 Q3	$1.01M	Sell	25,100 -34,200	-58%	-$1.77M	0.01%	562
2015 Q2	$3.41M	Buy	59,300 +28,000	+89%	+$1.78M	0.03%	443
2015 Q1	$1.99M	Buy	+31,300	New	+$2.12M	0.02%	516

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Korea Investment Corp's IONS Position: Q2 2021 in Review

Korea Investment Corp sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 29,900 shares — an estimated $1.34M sold.

Korea Investment Corp first reported a position in IONS in Q1 2015 and held it in 9 quarters. The position peaked at $3.41M in Q2 2015. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Korea Investment Corp reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Korea Investment Corp sold 29,900 Ionis Pharmaceuticals shares in Q2 2021, an estimated $1.34M.
Korea Investment Corp first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 9 quarters.
Korea Investment Corp's Ionis Pharmaceuticals position peaked at $3.41M in Q2 2015.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Korea Investment Corp's 13F filing for Q2 2021, filed 12 Aug 2021.